Xcout Intel
InSphero competitors & alternatives
The 12 closest competitors and alternatives to InSphero among biotech companies — ranked by similarity to what InSphero actually does, not by market-cap band.
Subscribe to see InSphero’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About InSphero
InSphero provides 3D in vitro cell culture models, microplates, organ-on-a-chip platforms, and related services for drug discovery and safety testing. The company serves pharmaceutical, biotechnology, and research organizations seeking non-animal testing alternatives to evaluate drug efficacy, liver safety, oncology, and other complex diseases.
InSphero at a glance
InSphero is a biotech company headquartered in Switzerland. Xcout tracks 19 named people at InSphero, including Olivier Frey (Chief Operating Officer & Chief Technology Officer).
InSphero leadership
- Olivier FreyChief Operating Officer & Chief Technology Officer
- Julian von SeyfriedChief Financial Officer
- Madhu NagChief Scientific Officer
- Jan LichtenbergCEO and Co-Founder
- Wolfgang MoritzHead of External Collaborations, Co-founder
- Alexandra TitleVice President, Islet Biology
13 more named people on record for InSphero, with roles, board committees and tenure — see the full roster →
Top 12 InSphero competitors
Ranked by semantic similarity — how close each company is to InSphero by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Hubrecht Organoid Technology (HUB) develops patented patient-derived organoid technology from healthy and diseased tissues to predict patient responses to treatments. The company functions as a contract research organization (CRO), offering drug discovery services, custom model and assay development, clinical trials in a dish, and licensing programs for pharmaceutical and research applications.
Biotechnology
genOway provides preclinical models and custom research solutions, including genetically modified mice, rats, and cell lines, to biopharmaceutical and academic researchers. The company specializes in creating tools such as humanized and conditional knockout models to support efficacy, safety, and pharmacokinetic assessments in drug discovery.
Biotechnology
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Similar biotech company
BICO provides lab automation software, instruments, biomaterials, and liquid handling solutions for life science research, drug discovery, and tissue engineering. The company serves pharmaceutical companies, biotechnology firms, and academic institutions by automating laboratory workflows and providing 3D bioprinting and imaging technologies.
Biotechnology
Axol Bioscience is a leading provider of iPSC-derived cells and related services, supporting neuroscience, ophthalmology, and cardiotoxicity drug discovery with advanced human disease models.
Biotechnology
Emulate, Inc. (Emulate) is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, testing how different medicines, chemicals, and foods affect human health. Emulate has also worked with Cedars-Sinai Medical Center on a precision medicine initiative that uses Organs-on-Chips technology in the clinical setting. This initiative is designed to provide clinicians with better data about how a
Similar biotech company
Biocytogen provides fully human antibody discovery services and preclinical contract research organization (CRO) services. The company offers genetically engineered animal models, cell lines, gene editing services, and in vivo and in vitro pharmacology studies to support biopharmaceutical research and drug development.
Similar biotech company
Mimetas is a privately owned biotechnology company developing human organ-on-a-chip tissue models and products for drug development. The company also is involved in the testing of chemicals along with food and personalized medicine applications. The company is based in Oegstgeest and Enschede, The Netherlands, with subsidiairies in Gaithersburg (MD), United States, and Tokyo, Japan. Mimetas was founded in 2011 by Paul Vulto, Jos Joore, Bas Trietsch and Thomas Hankemeier. The company is co-led by Joore and Vulto as CEOs.
Similar biotech company
Established in 2003 and headquartered in Yokohama, Japan, ReproCELL Incorporated operates as a prominent firm specializing in stem cell research. The company furnishes an extensive portfolio of products crucial for various stem cell applications, including a diverse array of specialized reagents for RNA reprogramming, cell growth (such as small molecules, growth factors, and cytokines), cell characterization (like antibodies and staining kits), cell culture (including pluripotent stem cell media and cell substrates), and cell handling (such as cryopreservation media, dissociation solutions, and transfection reagents). Furthermore, ReproCELL provides differentiated induced pluripotent stem cells (iPSCs), related components like feeder cells and induced neurons, 3D cell culture systems, and general laboratory consumables. Complementing its product lines, the company offers a comprehensive suite of services, spanning preclinical genomics, dedicated stem cell research, drug development support (encompassing efficacy, safety, and ADME analyses), access to human tissue samples, therapeutic pipeline development, and a range of clinical services, including laboratory diagnostics and the creation of GMP iPSC master cell banks.
Biotechnology
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Life Sciences
INDIGO Biosciences, Inc. provides life science solutions, specializing in in vitro cell-based reporter assay systems and screening services for pharmaceutical and research markets. Headquartered in State College, Pennsylvania, the company supports environmental, toxicological, and drug discovery testing.
Biotechnology
Deep Cell Industries Inc. provides an AI-integrated platform called REM-I that combines label-free imaging, deep learning, and cell enrichment for single-cell morpholomic analysis. The company serves researchers and organizations in oncology, drug discovery, cell and gene therapy, and related life science fields by enabling high-resolution profiling and sorting of viable cells.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of InSphero and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for InSpheroand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →